These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 36979003)
21. Diabetic Cardiomyopathy: An Immunometabolic Perspective. Mishra PK; Ying W; Nandi SS; Bandyopadhyay GK; Patel KK; Mahata SK Front Endocrinol (Lausanne); 2017; 8():72. PubMed ID: 28439258 [TBL] [Abstract][Full Text] [Related]
22. Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance. Rahimi Y; Camporez JP; Petersen MC; Pesta D; Perry RJ; Jurczak MJ; Cline GW; Shulman GI Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16508-13. PubMed ID: 25368185 [TBL] [Abstract][Full Text] [Related]
23. The impact of FOXO-1 to cardiac pathology in diabetes mellitus and diabetes-related metabolic abnormalities. Chistiakov DA; Orekhov AN; Bobryshev YV Int J Cardiol; 2017 Oct; 245():236-244. PubMed ID: 28781146 [TBL] [Abstract][Full Text] [Related]
24. Reduced effects of L-carnitine on glucose and fatty acid metabolism in myocytes isolated from diabetic rats. Abdel-aleem S; Karim AM; Zarouk WA; Taylor DA; el-Awady MK; Lowe JE Horm Metab Res; 1997 Sep; 29(9):430-5. PubMed ID: 9370110 [TBL] [Abstract][Full Text] [Related]
25. Acetylation of mitochondrial proteins by GCN5L1 promotes enhanced fatty acid oxidation in the heart. Thapa D; Zhang M; Manning JR; Guimarães DA; Stoner MW; O'Doherty RM; Shiva S; Scott I Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H265-H274. PubMed ID: 28526709 [TBL] [Abstract][Full Text] [Related]
26. FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes. Yan D; Cai Y; Luo J; Liu J; Li X; Ying F; Xie X; Xu A; Ma X; Xia Z J Cell Mol Med; 2020 Jul; 24(14):7850-7861. PubMed ID: 32450616 [TBL] [Abstract][Full Text] [Related]
27. Iron overload and diabetes risk: a shift from glucose to Fatty Acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Huang J; Jones D; Luo B; Sanderson M; Soto J; Abel ED; Cooksey RC; McClain DA Diabetes; 2011 Jan; 60(1):80-7. PubMed ID: 20876715 [TBL] [Abstract][Full Text] [Related]
28. Hyperpolarized NMR study of the impact of pyruvate dehydrogenase kinase inhibition on the pyruvate dehydrogenase and TCA flux in type 2 diabetic rat muscle. Park JM; Josan S; Hurd RE; Graham J; Havel PJ; Bendahan D; Mayer D; Chung Y; Spielman DM; Jue T Pflugers Arch; 2021 Nov; 473(11):1761-1773. PubMed ID: 34415396 [TBL] [Abstract][Full Text] [Related]
29. Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy. Zamora M; Villena JA Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212580 [TBL] [Abstract][Full Text] [Related]
30. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation. Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899 [TBL] [Abstract][Full Text] [Related]
31. Mechanism of pyruvate dehydrogenase activation by increased cardiac work. Kobayashi K; Neely JR J Mol Cell Cardiol; 1983 Jun; 15(6):369-82. PubMed ID: 6876186 [TBL] [Abstract][Full Text] [Related]
32. Ablating the Rab-GTPase activating protein TBC1D1 predisposes rats to high-fat diet-induced cardiomyopathy. Barbeau PA; Houad JM; Huber JS; Paglialunga S; Snook LA; Herbst EAF; Dennis KMJH; Simpson JA; Holloway GP J Physiol; 2020 Feb; 598(4):683-697. PubMed ID: 31845331 [TBL] [Abstract][Full Text] [Related]
33. Loss of cardiac PFKFB2 drives Metabolic, Functional, and Electrophysiological Remodeling in the Heart. Harold KM; Matsuzaki S; Pranay A; Loveland BL; Batushansky A; Mendez Garcia MF; Eyster C; Stavrakis S; Chiao YA; Kinter M; Humphries KM bioRxiv; 2023 Nov; ():. PubMed ID: 38045353 [TBL] [Abstract][Full Text] [Related]